Rick Gonzalez’s Legacy and AbbVie’s Future under Robert Michael
Rick Gonzalez, CEO of AbbVie, transformed Humira into the world's top-selling drug, defying politics and competition. [...]
Congressional Committee Threatens HHS with Compulsion Over Covid-19 Inquiry
The House Select Subcommittee on the Coronavirus Pandemic, led by Chairman Rep. Brad Wenstrup (R-Ohio), is [...]
Gilead Sciences Faces Setbacks with Magrolimab in Solid Tumor Trials
Gilead Sciences has encountered significant challenges with its anti-CD47 monoclonal antibody, magrolimab, leading to a pause [...]
Biden Administration Boosts Long Covid Research Funding by $515 Million
The Biden administration has announced a substantial increase in funding for long Covid research, adding $515 [...]
Advocacy Group Targets Congressman Over Drug Pricing Bill
Patients For Affordable Drugs Now (P4ADNow) has initiated a campaign against Rep. Don Davis (D-N.C.) through [...]
Study Reveals Long-Term Immune System Damage from Smoking
Recent research published in Nature has shed new light on the long-lasting adverse effects of smoking [...]
GSK Advances Oligonucleotide Research with Elsie Biotechnologies Platform License
GlaxoSmithKline (GSK) has solidified its commitment to oligonucleotide therapeutics by securing a nonexclusive license to Elsie [...]
Biogen CEO Optimistic Despite Financial Challenges, Eyes Growth with New Drug Launches
Chris Viehbacher, Biogen’s CEO, remains optimistic about the company’s future despite current financial difficulties. Biogen has [...]
FDA Approves Takeda’s Eohilia: A Breakthrough Oral Treatment for Eosinophilic Esophagitis
The U.S. Food and Drug Administration (FDA) recently approved Takeda's Eohilia, marking the introduction of the [...]
Study Reveals Ebola Vaccine’s Potential to Save Lives Even After Infection
A recent study has provided significant insights into the efficacy of the Ebola vaccine, particularly in [...]
Pharma CEOs Defend Drug Pricing Practices at Senate Hearing Amid Calls for Reform
CEOs from Johnson & Johnson, Merck, and Bristol Myers Squibb testified before the Senate Health, Education, [...]
Kyverna Therapeutics Raises $319 Million in IPO, Advances Autoimmune Cell Therapy Research
Kyverna Therapeutics, under CEO Peter Maag, Ph., has recently completed a $319 million Initial Public Offering [...]
Study Challenges Efficacy of High-Dose Naloxone in Opioid Overdose Survival, Raises Concerns Over Cost and Withdrawal Symptoms
A study published in the CDC's Morbidity and Mortality Weekly Report found no significant survival advantage [...]
Eli Lilly Settles Lawsuit with Minnesota to Cap Insulin Prices at $35 and Donate to Clinics
Eli Lilly has agreed to a settlement to provide low-cost insulin to Minnesota patients, addressing a [...]
Gilead Halts Magrolimab Blood Cancer Development After Increased Mortality Risk
Gilead Sciences is halting the development of magnolia for blood cancer, including acute myeloid leukemia (AML) [...]
Joshua Boger Takes Chair at CervoMed, Eyes Potential Breakthrough in Dementia Treatment with Neflamapimod
Joshua Boger, the former CEO of Vertex Pharmaceuticals, has selectively accepted a new role as chair [...]
House Hearing Addresses Drug Shortages and Manufacturing Challenges in the U.S.
At a House Ways and Means Committee hearing, the issue of chronic drug shortages in the [...]
AstraZeneca Invests $300 Million in New Cell Therapy Facility in Maryland, Creating Over 150 Jobs
AstraZeneca announced a $300 million investment in a new facility in Rockville, Maryland, dedicated to discovering [...]
Key Insights from the 2025 Medicare Advantage Proposals: A Cautious Approach in an Election Year
The 2025 Medicare Advantage (MA) proposals introduced by CMS indicate a cautious approach by the Biden [...]
The Rise of GLP-1 Influencers: Celebrity Endorsements and Social Media’s Role in the Ozempic Weight Loss Craze
The "Ozempic craze" refers to the growing popularity of GLP-1 drugs for weight loss, driven by [...]
Keytruda Surpasses Comirnaty to Become World’s Top-Selling Drug in 2023
Merck’s Keytruda has emerged as the world’s top-selling drug in 2023, with sales reaching $25 billion, [...]
Publicis Health Agrees to $350 Million Settlement Over Opioid Crisis Involvement
Publicis Health has agreed to a $350 million settlement to address its involvement in the opioid [...]
Medicare Begins Price Negotiations Under Inflation Reduction Act, Pharma Companies Stay Silent
The Centers for Medicare & Medicaid Services (CMS) has initiated Medicare price negotiations for the first [...]
CDC Study Finds Latest Covid-19 Booster 54% Effective Against Infection
The CDC reported that the latest COVID-19 booster is about 54% effective against infection, including the [...]
FDA Plans Major Reforms to Advisory Committee Process, Aiming for Enhanced Expert Involvement
The FDA is planning significant reforms to its advisory committee process, as announced by Commissioner Rob [...]